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Background: The ABC transporter CydDC, which pumps sulfur compounds, is required for assembly of the bacterial
respiratory machinery.
Results: ATP hydrolysis by CydCD in response to sulfur compounds is modulated by hemes.
Conclusion: Hemes regulate CydDC in pumping sulfur compounds.
Significance: This work is a first step in understanding the structure, function, and regulation of a protein vital to the assembly
of the respiratory machinery.
In Escherichia coli, the biogenesis of both cytochrome bd-
type quinol oxidases and periplasmic cytochromes requires the
ATP-binding cassette-type cysteine/GSH transporter, CydDC.
Recombinant CydDC was purified as a heterodimer and found
to be an active ATPase both in soluble form with detergent and
when reconstituted into a lipid environment. Two-dimensional
crystals of CydDC were analyzed by electron cryomicroscopy,
and the protein was shown to be made up of two non-identical
domains corresponding to the putative CydD and CydC sub-
units, with dimensions characteristic of other ATP-binding
cassette transporters. CydDC binds heme b. Detergent-solubi-
lized CydDC appears to adopt at least two structural states, each
associated with a characteristic level of bound heme. The puri-
fied protein in detergent showed a weak basal ATPase activity
(approximately 100 nmol Pi/min/mg) that was stimulated
3-fold by various thiol compounds, suggesting that CydDC
could act as a thiol transporter. The presence of heme (either
intrinsic or added in the form of hemin) led to a further
enhancement of thiol-stimulated ATPase activity, although a
large excess of heme inhibited activity. Similar responses of the
ATPase activity were observed with CydDC reconstituted into
E. coli lipids. These results suggest that heme may have a regu-
latory role in CydDC-mediated transmembrane thiol transport.
Escherichia coli has a complex branched respiratory electron
transport system that enables the bacterium to exploit various
terminal electron acceptors (1). During aerobic growth, the qui-
none pool of the inner membrane is used to reduce molecular
oxygen to water, the process being mediated by one of the two
major membrane-bound respiratory terminal oxidases, cyto-
chrome bo (encoded by the cyoABCDE operon) and bd-I
(encoded by the cydAB operon) (2, 3). Both complexes are elec-
trogenic proton translocators, serving as energy coupling sites
for oxidative phosphorylation (4, 5).
Assembly of functional cytochrome bd-type quinol oxidases
requires not only the structural genes but also the gene prod-
ucts of an unlinked cydDC operon (6, 7). On the basis of both
the observed gene structure and deduced protein sequences,
CydDC is postulated to form a heterodimeric ATP-binding cas-
sette (ABC)6 transporter with two transmembrane domains
(TMDs), each predicted to comprise six TM -helices and two
nucleotide binding domains (8). The two constituent polypep-
tides exhibit 27% identity, and the calculated molecular masses
for CydD and CydC are 64 and 63 kDa, respectively. Paralogues
of CydDC include MsbA (26% sequence identity), an inner
membrane lipid flippase that, in turn, is closely related to
eukaryotic multidrug export proteins such as P-glycoprotein,
MRP1, and MRP2 (9, 10).
The periplasm of E. coli mutants lacking functional CydDC
has been reported to be “overoxidized” (11). This finding sub-
sequently led to the identification of two substrates for this
transporter, cysteine (12) and reduced GSH (13). The pheno-
type of the cydD mutant strain is pleiotropic, exhibiting sensi-
tivity to benzylpenicillin and DTT, loss of motility, and the
absence of holocytochrome c. These characteristics are also
shared by E. coli dsb mutants (14), suggesting defective disulfide
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bond formation/isomerization as a possible cause of these traits
in strains lacking a functional CydDC complex. These pheno-
types, together with the loss of periplasmic cytochrome b562 (a
typical cydD phenotype), can all be corrected by the addition
of cysteine or GSH to the growth medium (12, 13). Further-
more, the cydD mutant has been shown to contain elevated
cysteine levels in the cytoplasm (12). These studies suggest a
role for CydDC in relaying the cytoplasmic reducing power to
the periplasm.
The dependence of cytochrome bd assembly on CydDC also
suggests a specific involvement of CydDC in heme processing
(15), although a role in heme translocation seems unlikely.
Heme incorporation into various exogenous hemoproteins
occurs in the periplasm of a cydC strain (11), and the uptake of
radiolabeled heme into inverted E. coli membrane vesicles
occurs through a mechanism independent of ATP hydrolysis
(15). However, the involvement of CydDC-mediated glutathi-
one/cysteine translocation in hemoprotein assembly is sup-
ported by the observation that CydDC overexpression under
anaerobic conditions leads to the accumulation of the heme
compound P-574 associated with the inner membrane (16).
Additionally, anaerobically grown E. coli-overexpressing CydDC
was subsequently found to contain a heme-bound form of
NikA, a periplasmic nickel chaperone (17). These observations
point toward a role for CydDC in maintaining an optimum
periplasmic redox poise that is required for the incorporation of
heme cofactors into respiratory complexes and periplasmic
hemoproteins.
To understand more precisely the biochemical role of
CydDC, we first need to characterize the nature of the putative
heterodimeric assembly and how potential substrates might
interact with it. As part of this approach, we attempted to purify
the protein for structural studies. Crucial components of these
structural studies have been the need to assay ATPase activity
and the search for potential substrates and substrate analogues
to aid in crystallization. In this work, we provide a direct dem-
onstration of the hitherto putative heterodimeric assembly of
CydDC and show, with extensive analysis of a CydDC-heme
complex, that the ATPase activity of this ABC transporter
responds strongly to thiol and heme compounds.
EXPERIMENTAL PROCEDURES
Materials—Reagents and their sources were as follows: yeast
extract (Oxoid, Cambridge, UK); Bacto-tryptone and bacto-
agar (BD Biosciences); n-dodecyl--D-maltoside (DDM) and
n-decyl--D-maltoside (Glycon, Germany); E. coli total/polar
lipid extracts (Avanti Polar Lipids, Alabaster, AL); tris(2-car-
boxyethyl)phosphine (Pierce); phosphotungstic acid (Sigma-
Aldrich, Poole, UK); and uranyl formate (Polysciences, War-
rington, PA).
Cloning and Overexpression of C-His6-CydDC—The cydDC
operon from pRKP1602 (16) was subcloned into the EcoRI and
PstI sites of the expression plasmid pTTQ18 (18). The resultant
construct, pHX100, encoded CydD with an NS insertion
between residues 2 and 3 of the wild-type sequence, arising
from the cloning procedure, and CydC bearing a C-terminal
SAGGRGSH6 tag (C-His6-CydDC). The ribosome binding site
for translation of the CydD coding sequence is provided by the
vector, and a likely ribosome binding site for translation of
CydC lies close to the 3 end of the CydD gene.
E. coli BL21 harboring pHX100 was grown in 500 ml of M9
medium containing 50 g/ml carbenicillin supplemented with
0.2 mM CaCl2, 0.2% glycerol, 2 mM MgCl2, and 0.2% casamino
acid and incubated with shaking at 220 rpm at 37 °C for 16 h in
2-liter conical flasks. Isopropyl 1-thio--D-galactopyranoside
was then added to a final concentration of 0.6 mM, and the cells
were induced for 3 h at 220 rpm and 37 °C. Harvested cells were
stored at 70 °C until required.
Absorption Spectroscopy—For the whole-cell carbon monox-
ide difference spectra, E. coli AN2342 (cydD, referred to as the
wild type) and its isogenic cydD mutant derivative, AN2343,
with/without pHX100, were grown under identical conditions
as above. Cells from 500-ml cultures were harvested (2000  g,
20 min, 4 °C) and resuspended in 15 ml of 100 mM phosphate
buffer (pH 7.0). The CO-reduced minus reduced difference
spectra of whole cells were recorded at room temperature as
described in Ref. 19. The protein sample was treated in the same
way as described for whole cells, and the identity of bound heme
b was confirmed by recording pyridine hemochrome difference
spectra as in Ref. 20. The Markwell method (21) was used to
determine protein concentrations. Heme b concentrations
were determined using an absorption coefficient of 20.7
mM/cm from A557–541 (22).
Preparation of E. coli Membrane Fractions—All steps were
carried out at 4 °C. Cell pellets were resuspended at 0.4 g (wet
weight)/ml in 20 mM Tris-HCl (pH 7.5), 0.5 mM EDTA. After
incubation for 30 min, DNase and RNase were added to final
concentrations of 20 g/ml and MgSO4 to a final concentration
of 10 mM. The suspension was stirred for 30 min, and cells were
disrupted by passage through a French pressure cell at 20,000
psi. The lysate was cleared by centrifugation at 10,000  g for 60
min. Membranes were collected by centrifugation at 131,000 
g for 90 min. The membrane pellet was washed three times with
20 mM Tris-HCl (pH 7.5) by ultracentrifugation for 60 min at
131,000  g between each wash. The final membrane pellet was
homogenized in 20 mM Tris-HCl (pH 7.5) at a protein concen-
tration of 30 – 60 mg/ml determined using a BCA protein assay
kit (Pierce).
Solubilization and Purification—All steps were carried out at
4 °C. The washed membranes (240 –270 mg protein) were sol-
ubilized by incubation for 1 h in 20 mM Tris-HCl (pH 8.0), 20%
glycerol, 300 mM NaCl, 10 mM imidazole, and 1% DDM to yield
a concentration of 4 mg/ml. The remaining insoluble mate-
rial was pelleted by ultracentrifugation at 100,000  g for 1 h.
The supernatant was mixed with 1.5 ml of prewashed (in col-
umn equilibration buffer, see below) Ni-NTA resin (Qiagen)
and incubated overnight with gentle rocking. The incubated
resin was packed into a polypropylene column and washed at 2
ml/min with 70 column volumes of the equilibration buffer (20
mM Tris-HCl (pH 8.0), 20% glycerol, 500 mM KCl, 10 mM imid-
azole, and 0.1% DDM). The bound protein was eluted at 2
ml/min with 7 column volumes of elution buffer containing 20
mM Tris-HCl (pH 8.0), 20% glycerol, 200 mM imidazole, and
0.02% DDM. Peak fractions were pooled and then concentrated
on a Viva-Spin concentrator molecular weight cut-off ((MWCO)
100,000, Sartorius), giving a typical yield of 1.5–2 mg of protein.
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The latter was then loaded onto three Superdex 200 10/300 GL
gel filtration columns connected in tandem (GE Healthcare),
equilibrated with gel filtration buffer (20 mM Tris-HCl (pH 8.0),
20% glycerol, and 0.02% DDM), and then the separation was
performed on an ÄKTA FPLC system (GE Healthcare) at a flow
rate of 0.1 ml/min. Each of the FPLC fractions was analyzed using
two wavelengths: 280 nm for the protein and 410 nm for the pig-
ment component. The peak fractions were pooled and stored at
80 °C following snap-freezing in liquid N2. No loss in ATPase
activity was detected following storage for 2 weeks under these
conditions, and 80% of activity was retained following storage at
4 °C for the same period. Proteins prepared for the crystallization
trials were used immediately after each of the purification runs.
N-terminal Amino Acid Sequencing—The N-terminal amino
acid sequences of proteins separated by SDS-PAGE and then
transferred by electroblotting to PVDF membrane were deter-
mined using a PerkinElmer Life Sciences (Applied Biosystems)
model 477A automated amino acid sequencer by Dr. J. N. Keen
at the University of Leeds Protein Sequencing Facility.
Circular Dichroism Spectroscopy—CD spectra of gel filtra-
tion peak fractions were recorded on a Jasco J-810 spectropolarim-
eter using a 2-mm cell at room temperature. Protein samples were
prepared at 0.2 mg/ml in 20 mM phosphate buffer (pH 7.5), 20%
glycerol, 0.02% DDM, and 0.01% dimethyl sulfoxide, and spectra
were collected from 200–260 nm with a 1.0-nm interval.
Reconstitution of C-His6-CydDC in E. coli Lipids—Reconsti-
tution of the purified C-His6-CydDC was performed essentially
as described for MsbA lipid flippase (23). Purified C-His6-
CydDC was mixed with destabilized (by 2 mM DDM) liposomes
of E. coli polar lipids (EPL) in 50 mM citrate (trisodium) buffer
(pH 6.0), and the detergent was removed by successive addi-
tions of BioBeads SM-2 (Bio-Rad) over a period of 2 days. The
amount of protein was estimated using the BCA assay. The total
phospholipid content was determined as described in Ref. 23.
ATPase Assay—The ATPase activity of purified C-His6-
CydDC (in 0.02% DDM) was measured using a method adapted
from Ref. 23. Reaction rates were measured at protein concen-
trations between 10 and 24 g/ml. The standard ATPase reac-
tion mixture contained 50 mM Tris (pH 7.5 at 37 °C), 10 mM
MgCl2, 20% glycerol, 0.02% DDM, and 2 mM ATP. Glycerol and
DDM were omitted from the reaction mixture for the reactions
with the reconstituted C-His6-CydDC. Control reactions
received either the gel filtration buffer (for the DDM-solubi-
lized C-His6-CydDC) or EPL liposomes containing the equimo-
lar amount of total phospholipids (for the reconstituted pro-
tein). Quantification of liberated Pi was performed by a
colorimetric method (24). The assay was linear up to 400 M Pi.
Two-dimensional Crystallization of C-His6-CydDC—Puri-
fied protein (0.1 mg) was mixed with E. coli total lipids solubi-
lized in 20 mM Tris-HCl (pH 8.0), containing 20% glycerol and
2% n-decyl--D-maltoside at lipid:protein weight ratios be-
tween 0.2 and 0.4. The total volume of each sample was adjusted
to 100 l with the gel filtration buffer to yield a final protein
concentration of 1.0 mg/ml. The mixtures were incubated over-
night at 4 °C and then dialyzed against various dialysis buffers
(Fig. 5) in a home-built continuous-flow dialysis apparatus over
10 days at 20 °C (25, 26).
Labeling with Ni-NTA-Nanogold—Purified C-His6-CydDC
was mixed with 5 nm Ni-NTA Nanogold particles (Nano-
probes, Yaphank, NY) at a molar ratio of 2:1 (final concentra-
tions of 56 and 28 M, respectively) in 20 mM Tris-HCl (pH 7.6),
20% glycerol, 150 mM NaCl, and 0.02% DDM and incubated
briefly at room temperature. The mixture was concentrated in a
Viva Spin 4 concentrator (MWCO 100,000) to 0.5 ml and clar-
ified by centrifugation at 16,000  g for 10 min at 4 °C.
Unbound gold particles were separated by applying the super-
natant onto a Superose 12 10/300 GL column (GE Healthcare)
equilibrated with 20 mM Tris-HCl (pH 7.6), 20% glycerol, 300
mM NaCl, 10 mM imidazole, and 0.02% DDM. Separation was
performed on an ÄKTA FPLC system at a flow rate of 0.3
ml/min. Labeling of the C-His6-CydDC-EPL proteoliposomes
was performed as above, but the glycerol and DDM were omit-
ted from the binding buffer, and the free gold label was removed
by washing the liposomes three times in 20 mM Tris-HCl (pH
7.6), 300 mM NaCl, and 10 mM imidazole by passing the pellet
through a 27-gauge needle several times, followed by centrifu-
gation at 16,000  g for 10 min at 4 °C.
Electron Microscopy—Samples were applied to carbon-
coated copper grids (400 mesh, Agar Scientific) after glow-dis-
charging in air. Samples were stained with 0.75% (w/v) uranyl
formate or 2% (w/v) phosphotungstic acid. For ice embedding,
the sample was applied to a Vitrobot system (FEI), blotted, and
frozen in liquid ethane. Imaging of stained samples was per-
formed at a magnification of 40,000 on a Philips CM100 at
100 kV, incorporating a Gatan MultiScan 794 1K  1K charge-
coupled device camera. For low-dose (10 e/Å2) cryoimag-
ing, micrographs were recorded at a magnification 60,000 on
a Philips CM200 FEG operating at 200 kV in conjunction with a
Gatan MegaScan 795 2K  2K charge-coupled device camera.
Image Processing—Image processing followed procedures
described previously (27, 28) using “MRC” and “2dx” software (29).
Statistical Analysis—Data points in the kinetic data represent
the mean 	 S.E. calculated using datasets from three indepen-
dent measurements. Non-linear curve fitting was performed
using either SigmaPlot (Systat Software Inc., San Jose, CA) or
OriginPro 7 (OriginLab, Northampton, MA).
RESULTS
Complementation of a cydD Mutant Strain with His-tagged
CydDC—Loss of functional CydDC results in the loss of the
heme d spectroscopic signal associated with the cytochrome bd
terminal oxidase (7). Fig. 1 confirms that loss of cydD abolishes
the heme d peak at 650 nm and that pHX100 can provide a
partial restoration of cytochrome bd assembly in cydD cells.
These data demonstrate that the His-tagged CydDC is func-
tional in vivo. The fact that this restoration is partial may be due
to the expression of high levels of CydDC being produced by the
tac promoter. Too much reduced thiol in the periplasm may
also perturb heme d incorporation.
Overexpression and Purification of C-His6-CydDC—CydDC
was estimated to be expressed at more than 1% of the total inner
membrane protein. The SDS gel in Fig. 2 shows that, after a
single affinity chromatography step, the preparation is highly
enriched in CydDC (Fig. 2, lane 5). Subsequent gel filtration
chromatography further resolved the affinity-purified protein
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into three protein peaks (Fig. 3a). SDS-PAGE analysis revealed
that all of these peaks are comprised of C-His6-CydDC (com-
pare lanes 6 – 8 in Fig. 2 with the gel image in Fig. 3a; peak 1 data
not shown). Peak 1 was coincident with the column void vol-
ume and yielded protein aggregates. The folding states of
CydDC in the two major peak fractions were found to be very
similar, with a large -helical content (Fig. 3c). The small spec-
tral differences for the two fractions may indicate differences in
conformation or may reflect uncertainty in concentration esti-
mates through variation in iron content. Electron microscopy
of peak 2 and 3 fractions revealed well dispersed particles, with
those from peak 2 larger and more elongated (approximately 15
nm) than those from peak 3 (approximately 10 nm in the lon-
gest dimension) (Fig. 3b). Following incubation with Ni-NTA
Nanogold, most of these particles were labeled with one gold
cluster (Fig. 3b, insets), suggesting that each particle contains a
single CydC subunit. This, together with the appearance of two
bands of equal intensity in the gel images in Figs. 2 and 3 (the
identities of which were confirmed by sequencing of the six
N-terminal residues), indicates that each particle in the elec-
tron micrographs in Fig. 3b corresponds to a single CydDC
heterodimer. The differences in size and shape implied by gel
filtration chromatography (Fig. 3a) and electron microscopy
(Fig. 3b) might reflect differences in conformation rather than
different aggregation states. However, there was a tendency for
particles to aggregate after gold labeling.
The pure protein had a deep brown color, and spectroscopic
analysis indicated that this arose from a b-type heme. The
greater part of this heme component comigrated with peak 3
(Fig. 3a). The more populated peak 2 fractions, when pooled,
yielded sufficient protein for crystallization trials. The pig-
ment-rich peak 3 fractions were selected for the identification
of the heme type by difference spectroscopy. Both fractions
were used in the ATPase assays, but the majority of the charac-
terization was performed on the peak 2 fractions, taking advan-
tage of its much greater yield.
Identification of the Pigment Component Copurified with
C-His6-CydDC—The absorption spectrum recorded from the
pooled peak 3 fractions exhibits a Soret peak at 412 nm and peaks
at 535 and 563 nm (Fig. 4a). This is characteristic of a low-spin
b-type heme (30). The reduced minus oxidized pyridine hemo-
chrome difference spectrum displayed peaks at 526 and 556 nm
(Fig. 4b) that match the peak positions for the pyridine hemo-
chrome of heme b (20). The heme b concentration in the com-
bined peak 3 fractions (Fig. 3) was measured as 0.87 M, which
FIGURE 1. CO-reduced, minus-reduced, room temperature, whole-cell absorption spectra showing the restoration of the ferrous CO-bound heme d
signal (maximum around 650 nm, see the inset showing the enlarged image of the - and -band regions) in the cydD mutant E. coli strain AN2343
(7) upon transformation with the C-His6-CydDC expression plasmid pHX100. IPTG, isopropyl 1-thio--D-galactopyranoside.
FIGURE 2. Coomassie-stained SDS-polyacrylamide gel showing the inter-
mediate samples in the purification. The amount of protein loaded in each
lane was 13 g unless stated otherwise. Lane M, molecular weight markers.
Lane 1, mixed inner and outer membranes from E. coli BL21/pHX100. Lane 2,
supernatant after incubation with the Ni-NTA resin. Lane 3, sedimented pellet
(3.3 g) after solubilization of membranes with 1% DDM. Lane 4, proteins
eluted from the nickel column during column wash. Lane 5, elution from the
nickel column with elution buffer (2.0 g). Lanes 6 and 7, elution after gel
filtration (as peak 2, see Fig. 3), 2.0 and 0.5 g, respectively. Lane 8, elution
after gel filtration (as peak 3, see Fig. 3) (1.0 g). Electrophoresis was per-
formed using precast NuPAGETM 10% BisTris gels (Invitrogen) in combina-
tion with NuPAGETM MOPS SDS running buffer (Invitrogen).
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gives a heme b:protein molar ratio of 1:5. Comparison of the
peak areas in the A280 nm and A410 nm traces between peaks 2 and 3
in Fig. 3a gives a pigment:protein ratio of 1:26 for peak 2.
Electron Microscopy of C-His6-CydDC Two-dimensional
Crystals—Purified C-His6-CydDC was reconstituted into
E. coli lipids at lipid:protein ratios of 0.2– 0.5 (w/w) to form
two-dimensional crystals. At the optimum pH of 6.0, CydDC
crystallized in three distinct forms, the formations of which
were dependent on the type of buffer salt used and also on the
concentration of Mg2 in the dialysis buffer (Fig. 5). Tubular
crystals were obtained at a particularly high yield. The type of
tubular crystal illustrated in Fig. 6a proved to be the most trac-
table for image analysis. Projection maps were calculated from
four images of independent crystals, with a 66 Å, b 160 Å,
and  90° on average. Unit cell dimensions were highly vari-
able both within and between images, therefore limiting the
resolution to about 30 Å. Phases were consistent with p121 sym-
metry. This crystal was formed of an array of dimeric units
arranged in alternating “up” and “down” orientations when
viewed perpendicular to the putative membrane plane (Fig. 6b).
Alternating orientations of the extramembrane domain can be
seen in “side” view in negatively stained crystals (Fig. 7). The
asymmetric unit contains two non-equivalent density peaks
that we interpret as representing the densities of the CydD and
CydC subunits. Two possible envelopes for the putative CydDC
heterodimer are outlined. The projected area enclosed by these
two alternative envelopes is consistent with that found for other
dimeric ABC transporters (31).
ATPase Activity of Purified C-His6-CydDC (Peak 2) in 0.02%
DDM—Fig. 8a shows that purified C-His6-CydDC in 0.02%
DDM showed constant Mg2-dependent ATPase activity
(approximately 100 nmol Pi/min/mg) with a linear reaction
FIGURE 3. C-His6-CydDC gel filtration chromatography. a, top panel, elution profile for the affinity-purified C-His6-CydDC from three Superdex200 10/300 GL
columns connected in tandem. The solid line represents A280 nm.E represent heme absorption (A410 nm). Peak fitting for the A410 nm curve was performed using
a three-parameter Gaussian. Bottom panel, analysis of the peak fractions by SDS gel electrophoresis. Conditions were as described in the legend for Fig. 2. b,
electron micrographs showing the C-His6-CydDC particles (stained with 2% phosphotungstic acid) for the peak 2 and 3 fractions. Insets show equivalent
samples labeled with Ni-NTA Nanogold. c, CD spectra for the peak 2 and 3 fractions of C-His6-CydDC. The spectrum for the CydDC peak 2 overlaps with data
points for peak 2 plus 1 M and 100 nM hemin, respectively.
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time course over at least 30 min. This indicated that the struc-
tural integrity of the protein was not affected adversely during
the time of incubation. Substrate binding to ABC transporters
generally leads to the stimulation of their ATPase activities (32).
We observed that cysteine and GSH, shown previously to be
actively transported by CydDC (12, 13), induced an 3- to
4-fold stimulation of the ATPase activity of CydDC (Figs. 8a
and 9). These thiols stimulated the ATPase activity to similar
maximal extents, but cysteine was much more potent (EC50 

26 	 3 M) than GSH (EC50 
 307 	 34 M), as shown in Fig.
8b. Other types of thiols, including DTT, 2-mercaptoethanol,
and DL-homocysteine, similarly stimulated the ATPase activity
of CydDC, as shown in Fig. 9. Inhibition, rather than stimula-
tion, was observed with the three non-thiol reductants: L-ascor-
bic acid, sodium dithionite, and tris(2-carboxyethyl)phosphine
(Fig. 8a). This indicates that the thiol-induced stimulation was
not merely caused by the reduction of, for example, any of the
three cysteine residues of CydDC. The reason for the inhibition
of the ATPase activity by the non-thiol reductants is unclear.
We tested the response of the ATPase activity to two types of
porphyrin compounds, hemin and protoporphyrin IX (PPIX).
As shown in Fig. 8c, hemin is a very potent stimulator of CydDC
ATPase activity, with the EC50 being of the order of 50 nM, but
the dose-response curve showed that its effect becomes inhib-
itory at concentrations above 1 M. At the optimum concen-
tration of 1 M, hemin alone stimulated the basal ATPase activ-
ity 4-fold. Stimulation by hemin was further enhanced by GSH.
The basal activity was stimulated synergistically (8-fold) by 1
M hemin plus 5 mM GSH. GSH did not alter the EC50 for the
hemin-induced stimulation, but it noticeably suppressed the
inhibitory effect of hemin. The same dose-response analyses
were performed using PPIX, but the ATPase activity did not
change in response to this non-iron-containing porphyrin at
any concentrations tested (Fig. 8d).
Non-thiol structural analogues of the thiols GSH, (homo)-
cysteine, DTT, and 2-mercaptoethanol (see Fig. 9 for a com-
plete list of the compounds tested) were tested for their ability
to stimulate the ATPase activity. Because GSH is a tripeptide
comprising glutamate, cysteine, and glycine, the non-thiol
amino acid components of GSH were also tested for the stim-
ulation. Histidine and imidazole were tested as additional non-
thiol amino compounds. The results are summarized in Fig. 9.
Significant changes in ATPase activity were invoked only with
thiols and L-histidine, and the extent of the stimulation fell
within a similar range of 2- to 3-fold. ATPase activity was also
enhanced by many of the other compounds, but the extent of
stimulation was much smaller, 1.2- to 1.5-fold.
The response of the ATPase activity of CydDC to the above
compounds was next characterized in the presence of the porphy-
rins hemin or PPIX. As summarized in Fig. 9, a synergistic
response to thiols (except DTT) or L-histidine occurred in the
presence of the iron protoporphyrin hemin. The extent of the
stimulation fell within the range of 8- to 9-fold. Other compounds
induced about a 6-fold stimulation in the presence of hemin, but
this level of stimulation was only slightly higher than that induced
by hemin alone. PPIX did not exhibit any stimulatory activity,
either alone or in combination with thiols or L-histidine, and, in
many cases, PPIX was seen to slightly inhibit ATPase activity. The
reason for the response to tris(2-carboxyethyl)phosphine in the
presence of both PPIX and hemin is unclear.
ATPase Activity of Purified C-His6-CydDC (Peak 3) in 0.02%
DDM—As shown in Fig. 10a, the heme b-rich CydDC recov-
ered from peak 3 exhibited a linear reaction time course, and
the response of its basal activity to GSH was similar to that seen
with CydDC in the peak 2 fraction (Fig. 8a). However, it showed
a basal activity approximately twice as high, and the GSH-stim-
ulated activity was almost comparable with the “synergistically
stimulated” activity described for the peak 2 fraction in the
presence of added GSH and hemin. By contrast, its response to
hemin appeared less marked compared with that of peak 2, as
seen in Fig. 10b. The response of CydDC in peak 3 to added
hemin alone and to simultaneously added hemin and GSH
accounted only for 30 and 50% of the extents achieved by
CydDC in peak 2, respectively. However, the absolute values for
the ATPase activities of the peak 2 and peak 3 fractions in the
presence of both saturating hemin and GSH were similar at
863 	 105 and 660 	 49 mol Pi/min/mol CydDC, respectively.
FIGURE 4. Identification of heme. a, absorption spectrum of the pooled peak
3 fractions of C-His6-CydDC (0.6 mg/ml after concentration), with the inset
showing the magnified view of the -band region. b, overlay of the three
difference spectra (CO-reduced minus reduced (red-red), reduced minus oxi-
dized (red-ox) , and pyridine hemochrome-reduced minus oxidized) with the
position of signature peaks indicated. The spectra were offset for clarity.
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FIGURE 5. Gallery of the main forms of two-dimensional crystals of C-His6-CydDC. a, low magnification view of the tubular crystal form obtained with 20
mM trisodium citrate (pH 6.0), 20% glycerol, and 0.02% NaN3 as the dialysis buffer. b, higher magnification view of the tubular crystal form. Inset, computer-
generated Fourier power spectrum showing spots arising from the two layers of the flattened tube. c, platelet crystals obtained with 20 mM N-(2-acetamido)-
2-iminodiacetic acid (pH 6.0), 20% glycerol, and 0.02% NaN3 as the dialysis buffer with the Fourier power spectrum inset. d, ribbon-shaped crystals obtained at
elevated (i.e. 10 mM) Mg2 concentrations in the citrate buffer described in a. Inset, enlarged view of the crystals revealing the characteristic striped patterns
running perpendicular to the axis of crystal growth. These images were recorded of crystals stained with 0.75% uranyl formate.
FIGURE 6. Image analysis of CydDC crystals. a, low-dose image of the ice-embedded C-His6-CydDC tubular crystal recorded at liquid N2 temperature. b,
merged projection map calculated to 30-Å resolution with p121 symmetry imposed. One unit cell is outlined, and two possible molecule envelopes are
indicated by thick dashed lines. Contours are plotted at 0.17  root-mean-square density, and densities below the mean are represented by dashed lines.
Scale bar 
 50 Å.
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ATPase Activity of Purified C-His6-CydDC (Peak 2) Reconsti-
tuted into E. coli Lipids—The effects of a subset of the com-
pounds listed in Fig. 9 on CydDC ATPase activity were tested
using C-His6-CydDC-EPL proteoliposomes. The result of the
reconstitution was checked by electron microscopy after label-
ing with Ni-NTA Nanogold (Fig. 11b). The basal activity from
the reconstituted C-His6-CydDC showed a greater variability
between different preparations than the DDM-solubilized pro-
tein, the lowest measured activity being 70 nmol Pi/min/mg,
whereas the highest was 140 nmol Pi/min/mg. However, as
shown in Fig. 11a, the response profile obtained for the recon-
stituted protein generally correlated well with that of the DDM-
solubilized protein. GSH and hemin stimulated the ATPase
activity of CydDC 2- and 4-fold, respectively. A strong syner-
gistic 8-fold stimulation of the ATPase activity was induced by
the simultaneous presence of GSH and hemin, but PPIX had no
stimulatory effect, either alone or in combination with GSH.
DISCUSSION
Purification of the CydDC Heterodimer in Multiple Con-
formations—The principal and original aim of this work was to
isolate CydDC of sufficient quality and quantity for structure
determination. Milligram quantities of monodispersed protein
were purified, ATPase activity was demonstrated, and two-di-
mensional crystallization revealed a clear heterodimeric archi-
tecture. Although the genetic evidence is consistent with
CydDC functioning as a heterodimeric ABC transporter in vivo,
this had not been confirmed by any direct means (8, 12, 13). In
the overexpressed, His-tagged CydDC, the two subunits are not
covalently linked and, therefore, a CydC homodimer could
have been an unwanted product. However, the twin and equally
staining bands observed by SDS gel electrophoresis (Figs. 2 and
3), the binding of a single gold cluster per protein particle seen
in the gold labeling study (Fig. 3b, insets), and the visualization
of two domains of different density within the asymmetric unit
of two-dimensional crystals (Fig. 6b) provide very strong evi-
dence for the isolation of a heterodimer.
A combination of nickel affinity chromatography and high-
resolution gel filtration revealed two distinct populations of
protein particles, each associated with a heme b component.
The most abundant population (Fig. 3a, peak 2) consisted of
slightly elongated particles with dimensions of 6  15 nm and a
molar heme:protein ratio of 1:26. The minor population (Fig.
3a, peak 3) consisted of more spherical particles, 6 nm in diam-
eter, with a molar heme:protein ratio of 1:5. When subjected to
SDS gel electrophoresis, these two populations appeared iden-
tical (Fig. 2). However, the different retention volumes exhib-
ited under gel filtration (Fig. 3a), differences in shape revealed
by EM (Fig. 3b), and slight differences in CD spectra (Fig. 3c) all
point to the two fractions having different conformations.
Crystallization—Although CydDC appears to be a promising
candidate for structural studies, the resolution attained cur-
rently is sufficient only to reveal domain structure. The tubular
type of crystal illustrated in Figs. 5–7 was formed of an array of
dimeric units arranged in alternating up and down orientations
when viewed perpendicular to the putative membrane plane. It
is likely that each unit, consisting of two unequal densities, rep-
resents a CydDC heterodimer. The poor crystal order might
reflect high conformational flexibility, similar to that inferred
from the x-ray crystal structure of MsbA (33). The two popula-
tions of CydDC with varying heme content and different
dimensions (Fig. 3a, peaks 2 and 3) indicate the presence of at
least two conformations. In any attempt to improve crystal
quality, further biochemical characterization will be essential,
and this study represents the first steps in this direction.
Heme Binding—Purified CydDC is brown. Spectroscopic
analysis showed that this originates from copurifying heme b
(Fig. 4). That a heme can specifically interact with CydDC is
also indicated by the strong response of the ATPase activity to
nanomolar concentrations of hemin (Fig. 8, c and d).
The two putative conformers were associated with different
levels of copurifying heme (Fig. 3a). However, the addition of
hemin to the purified CydDC from peak 2 did not retard the gel
filtration retention volume to that of peak 3 (data not shown).
Similarly, no evidence was seen in the CD spectra or by EM (Fig.
3, b and c) for a change in conformation upon addition of hemin
to the CydDC in peak 2. The higher heme:protein ratio of peak
3 in Fig. 3a indicates that an appreciable population of CydDC
in this fraction forms a tight complex with a heme b. We
attempted a second round of gel filtration of the peak 3 fraction,
but we observed no equilibrium dissociation of the heme to
generate the peak 2 species. Therefore, the putative difference
in the conformation of CydDC in the two fractions may be the
result of some other factor than heme binding, with the two con-
formers having different resultant heme-binding occupancies.
ATPase Activity Stimulated by Thiols—The His6-tagged
CydDC construct used in this study provided a partial restora-
tion of cytochrome bd assembly in cydD cells, demonstrating
that the His-tagged CydDC is functional in vivo. The partial
restoration of the heme d signal is not surprising because Poole
FIGURE 7. Low-dose image of a negatively stained tubular crystal of
C-His6-CydDC. The arrows point out the periodic appearance of the ATPase
domains along the longer edge of the crystal, indicating that CydDC is packed
in alternating up and down orientations in the crystal. Inset, enlarged view of
the small vesicle showing the side view along the plane of the lipid layer. The
extramembranous ATPase domains are clearly captured in this image. The
crystals were stained in 0.75% uranyl formate.
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et al. (8) reported that the introduction of the wild-type cydC/D
gene(s) in trans to E. coli cydC/D mutants also resulted in lower
levels of heme d signal. Nevertheless, the growth of the mutant
on selective media was restored.
We focused here on measuring ATPase activity rather than
direct transport activity. This information could help in identi-
fying crystallization additives that lock the transporter into one
conformation and give insights into CydDC function. Prior to
this study, cysteine and GSH were the only confirmed sub-
strates of CydDC (12, 13). Our more extensive survey suggests
that CydDC might also mediate the export of other com-
pounds. This could be analogous to members of the ABCC
subfamily of ABC transporters, postulated to share a common
basic structural architecture with CydDC and including MRP1
and 2.7 They have been shown to export both GSH and its
conjugates with various physiological and xenobiotic com-
pounds (9). We tested various thiols and their analogues for the
stimulation of ATPase activity of the purified transporter in
detergent solution (Fig. 9). As reported for P-glycoprotein and
other ABC-type import/export systems, nucleotide hydrolysis
in the cytosolic nucleotide binding domains is generally stimu-
lated by the binding of the transport substrate in the binding
pocket in the TMDs (32). Conversely, those that compete with
canonical substrates for the binding site(s) but are lacking the
structural determinants for inducing the conformational
changes in the TMDs, such as substrate analogues, would not
trigger the stimulation of the ATPase activity (23, 35, 36). As
summarized in Fig. 9, the ATPase activity of DDM-solubilized
CydDC was stimulated by various thiol compounds but not by
their S-substituted/non-thiol analogues nor by non-thiol
reductants. Indeed, the basal activity of CydDC was inhibited
markedly by the non-thiol reductants tested (Figs. 8a and 9).7 Dean, M., http://www.ncbi.nlm.nih.gov/books/NBK3/.
FIGURE 8. ATPase activity of purified CydDC (peak 2). a, reaction time courses for the ATPase reaction catalyzed by the peak 2 gel filtration fraction measured
in the presence of 5 mM GSH or various non-thiol reductants (fitted lines for the non-thiol reductants (except sodium dithionite) not shown for clarity).
Dose-response curves for the ATPase activity of C-His6-CydDC (Fig. 3a, peak 2) in 0.02% DDM with cysteine/GSH (b), hemin (in the presence or absence of 5 mM
GSH) (c), and hemin/PPIX (in the presence or absence of 5 mM GSH) (d). The response curves shown for hemin in d are derived from the full dose-response curves
in c to facilitate the comparison with PPIX datasets. Curve fitting through the thiol/hemin datasets in b, c, and d used the logistic dose-response function of the
OriginPro 7 software. c, the fitting to each response curve dataset was performed separately against two subdatasets, each encompassing data points in the
rising (solid line) and the falling (dashed line) parts of the response curve. Each of the data points represents the mean 	 S.E. of multiple (n  3) protein
preparations produced from independent membrane preparations. TCEP, tris(2-carboxyethyl)phosphine.
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Our results also revealed a significant response of the CydDC
ATPase to L-histidine, but whether or not histidine is involved
in protein-heme interaction, as reported for an E. coli heme
channel, CcsBA (37), awaits further study.
This stimulation profile of CydDC ATPase activity was nota-
bly different from that of the purified mammalian ABC-type
GSH/GS-X exporter MRP1 (38), where the basal ATPase activ-
ity measured in 1% DDM/0.4% sheep brain phospholipids gave
150 nmol/min/mg with an ATP concentration of 2 mM. The
ATPase activity was stimulated 1.2-fold by GSH, whereas a
somewhat higher stimulation (i.e. 1.5-fold) was achieved by oxi-
dized glutathione. CydDC, although showing similar basal
activity, showed a greater (3-fold) response to GSH (Fig. 8a).
Fig. 9 reveals a clear propensity of the ATPase activity of CydDC
to respond to thiols. The extent of the stimulation became
much less marked when the thiol group was modified or sub-
stituted. These data, especially the thiol-dependent ATPase
kinetics of CydDC, support the notion that CydDC is unlikely
to be a general efflux pump for cysteine/GSH conjugates.
ATPase Activity Stimulated by Heme Compounds—As
shown in Figs. 8, c and d, and 9, a dose-dependent increase in
the ATPase activity of CydDC (peak 2) by hemin was observed,
and the highest activity was reached at a heme:protein ratio of
5:1. At a further excess of hemin, the effect became inhibitory,
but this was alleviated in the presence of millimolar concentra-
tions of GSH (Fig. 8d). The EC50 for hemin was 100 nM, which
lies close to the reported range of 100 nM for the physiological
concentration of heme (39).
Hemin and thiols together induced a strong synergistic stim-
ulation (Figs. 8c, 9, and 10b). However, neither the EC50 for
hemin nor the heme:protein ratio for the highest response (i.e.
5:1) changed when the dose-response analysis was performed
in the presence of GSH. The effect of thiol is, therefore, that its
presence increases the turnover rate of the ATPase cycle while
not affecting the binding of heme to CydDC.
The greater proportion of heme in the peak 3 fraction
appeared to be directly correlated with its approximate 2-fold
higher basal ATPase activity relative to that of the peak 2 frac-
tion (Figs. 8a and 10a). The dose-response curve in Fig. 8c
shows that, for the 2-fold enhancement of activity in the pres-
ence of GSH, a heme concentration of 40 nM is needed. Taking
into consideration the protein concentration in the ATPase
reaction, this corresponds to a heme:protein ratio of 1:5. The
ratio of 1:5 was also estimated from the spectroscopic analysis
of the peak 3 fraction. The weaker ATPase response by the
CydDC in peak 3 to hemin, as shown in Fig. 10b, is consistent
with the endogenous heme already having provided an
increased relative basal activity.
To exclude the possibility that hemin is a transport substrate,
a direct transport assay would be required. However, previous
studies showed that CydDC actively exports cysteine and GSH
(12, 13) but that it does not mediate an active transport of
FIGURE 9. Modulation of the ATPase activity of purified CydDC in 0.02% DDM by various compounds. ATPase activity of DDM-solubilized C-His6-CydDC
(Fig. 3a, peak 2) was measured in the standard reaction mixture described under “Experimental Procedures.” Test compounds were at 5 mM, except that hemin
and protoporphyrin IX were both at 1 M. Stock solutions of the heme compounds were made either in dimethyl sulfoxide (for hemin) at 20 mM or in 20 mM
NaOH (for protoporphyrin IX) at 1 mM. For the reactions with test compounds dissolved in dimethyl sulfoxide or NaOH, parallel control reactions containing
these solvents only were performed to correct for their effects on ATPase activity. The vertical dotted line at 100% indicates the basal activity level. The basal
activity refers to that achieved without any additive(s) and is represented by the No additive data in the Control category. Each of the data points represents the
mean 	 S.E. of multiple (n  3) protein preparations produced from independent membrane preparations. GSSG, oxidized glutathione (glutathione disulfide);
TCEP, tris(2-carboxyethyl)phosphine; 2-ME, 2-mercaptoethanol.
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hemin alone (15). The stimulation of ATPase activity of CydDC
by hemin, therefore, suggests the following two possibilities.
Heme may be cotransported by CydDC with thiols, or heme
may bind and enhance the rate of thiol export by CydDC, but
the heme itself is not transported. The second possibility seems
most likely. Heme b appears to form a stable complex with
CydDC in peak 3. Indeed, preincubation of the complex with ATP
and GSH at 37 °C (i.e. under the same condition as the ATPase
assay reaction) in advance of gel filtration did not cause the release
of the pigment from CydDC (data not shown). Such a tight inter-
action would appear to be incompatible with the bound heme b as
a transport substrate of CydDC. However, the bound heme b does
modulate the responses of CydDC to both hemin and GSH (Fig.
10b). The bound pigment acted to enhance both the basal activity
and the response of CydDC to GSH, whereas it suppressed the
transporter’s response to hemin. The absence of stimulation by
PPIX indicates that the stimulation of ATP hydrolysis by CydDC
involves the recognition of the central coordinating iron atom of
an iron porphyrin (Fig. 8d).
This profile of heme stimulation suggests that heme com-
pounds may up-regulate thiol transport. Whether the redox
states of the bound heme influence the ATPase activity of
CydDC, thereby serving as a mechanism to maintain a proper
redox poise in the extracytoplasmic space, was not addressed in
this study. It is an intriguing question, left to be answered in
future efforts. It is notable that the transport activity of ABC
exporters can be modulated by a group of non-substrate com-
pounds, called chemosensitizers, that bind to the TMDs rather
than at the binding site for the substrates and affect the confor-
mational coupling between the nucleotide binding domains
and the TMDs, therefore controlling transport activity (34).
Similar observations have been reported for the rod photore-
ceptor-specific ABC transporter ABCR (36).
FIGURE 10. ATPase activity of purified CydDC (peak 3). a, reaction time
courses for the ATPase reaction catalyzed by the peak 3 gel filtration fraction
measured in the presence or absence of 5 mM GSH. The activity from this
fraction showed an appreciable variability between independent batches.
Therefore, a typical result from a single batch is presented. b, modulation of
the respective basal ATPase activities of the peak 2 and 3 gel filtration frac-
tions by GSH and/or hemin. Each of the data points represents the mean 	
S.E. of multiple (n  3) protein batches produced from independent mem-
brane preparations. The activity data shown have been normalized to the
basal activities (100%) of the respective peak fractions.
FIGURE 11. ATPase activity of CydDC in the presence of lipid. a, ATPase
activity of C-His6-CydDC (Fig. 3a, peak 2) reconstituted into E. coli lipids. The
parallel control runs received equimolar (total phosphorus) amounts of EPL
small unilamellar vesicles. The rest of the procedure was the same as for deter-
gent-solubilized C-His6-CydDC. Each of the data points represents the
mean 	 S.E. of multiple (n  3) protein preparations produced from inde-
pendent membrane batches. b, an electron micrograph of the C-His6-CydDC-
EPL proteoliposomes after labeling with 5.0 nm Ni-NTA Nanogold. The sam-
ple was stained in 2% phosphotungstic acid. Scale bar 
 5 nm.
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